Literature DB >> 21881927

Validation of Tikhonov adaptively regularized gamma variate fitting with 24-h plasma clearance in cirrhotic patients with ascites.

Carl Adam Wesolowski1, Lin Ling, Elias Xirouchakis, Maria T Burniston, Richard C Puetter, Paul S Babyn, Ioannis G Giamalis, Andrew K Burroughs.   

Abstract

PURPOSE: The aim was to compare late-time extrapolation of plasma clearance (CL) from Tikhonov adaptively regularized gamma variate fitting (Tk-GV) and from mono-exponential (E1) fitting.
METHODS: Ten (51)Cr-ethylenediaminetetraacetic acid bolus IV studies in adults--8 with ascites--assessed for liver transplantation, with 12-16 plasma samples drawn from 5-min to 24-h, were fit with Tk-GV and E1 models and CL results were compared using Passing-Bablok fitting.
RESULTS: The 24-h CL(Tk-GV) values ranged from 11.4 to 79.7 ml/min. Linear regression of 4- versus 24-h CL(Tk-GV) yielded no significant departure from a slope of 1, whereas the 4- versus 24-h CL(E1) slope, 1.56, was significantly increased. For CL(Tk-GV-24-h) versus CL(E1-24-h), there was a biased slope and intercept (0.85, 5.97 ml/min). Moreover, the quality of fitting of 24-h data was significantly better for Tk-GV than for E1, as follows. For 10 logarithm of concentration curves, higher r values were obtained for each Tk-GV fit (median 0.998) than for its corresponding E1 fit (median 0.965), with p < 0.0001 (paired t-test of z-statistics from Fisher r-z transformations). The E1 fit quality degraded with increasing V/W [volume of distribution (l) per kg body weight, p = 0.003]. However, Tk-GV fit quality versus V/W was uncorrelated (p = 0.8).
CONCLUSION: CL(E1) values were dependent on sample time and the quality of fit was poor and degraded with increasing ascites, consistent with current opinion that CL(E1) is contraindicated in ascitic patients. CL(Tk-GV) was relatively more accurate and the good quality of fit was unaffected by ascites. CL(Tk-GV) was the preferred method for the accurate calculation of CL and was useful despite liver failure and ascites.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881927      PMCID: PMC3218286          DOI: 10.1007/s00259-011-1887-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  12 in total

1.  Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies.

Authors:  A H Calvert; M J Egorin
Journal:  Eur J Cancer       Date:  2002-01       Impact factor: 9.162

2.  Guidelines for the measurement of glomerular filtration rate using plasma sampling.

Authors:  John S Fleming; Maureen A Zivanovic; Glen M Blake; Maria Burniston; Philip S Cosgriff
Journal:  Nucl Med Commun       Date:  2004-08       Impact factor: 1.690

3.  The effect of improved modelling of plasma clearance in paediatric patients with expanded body spaces on estimation of the glomerular filtration rate.

Authors:  A S Perkinson; C J Evans; M T Burniston; S W Smye
Journal:  Physiol Meas       Date:  2009-12-16       Impact factor: 2.833

4.  Conventional measurements of GFR using 51Cr-EDTA overestimate true renal clearance by 10 percent.

Authors:  Amelia E B Moore; So-Jin Park-Holohan; Glen M Blake; Ignac Fogelman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-26       Impact factor: 9.236

5.  Glomerular filtration rate measurement by "single-shot" injection of inulin.

Authors:  K W Florijn; J N Barendregt; E G Lentjes; W van Dam; W Prodjosudjadi; J L van Saase; L A van Es; P C Chang
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

6.  A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I.

Authors:  H Passing
Journal:  J Clin Chem Clin Biochem       Date:  1983-11

7.  Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis.

Authors:  Elias Xirouchakis; Laura Marelli; Evangelos Cholongitas; Pinelopi Manousou; Vincenza Calvaruso; Maria Pleguezuelo; Gian Piero Guerrini; Sergio Maimone; Andrew Kerry; Mark Hajjawi; Devaki Nair; Michael Thomas; David Patch; Andrew Kenneth Burroughs
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-09       Impact factor: 8.237

8.  A Bayesian regression model for plasma clearance.

Authors:  Charles D Russell; Andrew T Taylor; Eva V Dubovsky
Journal:  J Nucl Med       Date:  2002-06       Impact factor: 10.057

9.  Optimum sample times for single-injection, multisample renal clearance methods.

Authors:  C D Russell
Journal:  J Nucl Med       Date:  1993-10       Impact factor: 10.057

10.  Patients with ovarian cancer have elevated (51)Cr-EDTA plasma clearance early post-operatively.

Authors:  S S Nielsen; H Havsteen; L K Petersen; L E Nielsen; M Rehling
Journal:  Nucl Med Commun       Date:  2002-09       Impact factor: 1.690

View more
  6 in total

Review 1.  Difficulties in diagnosing acute kidney injury post liver transplantation using serum creatinine based diagnostic criteria.

Authors:  Banwari Agarwal; Andrew Davenport
Journal:  World J Hepatol       Date:  2014-10-27

2.  The early plasma concentration of 51Cr-EDTA in patients with cirrhosis and ascites: a comparison of three models.

Authors:  Surajith N Wanasundara; Michal J Wesolowski; Richard C Puetter; Maria T Burniston; Elias Xirouchakis; Ioannis G Giamalis; Paul S Babyn; Carl A Wesolowski
Journal:  Nucl Med Commun       Date:  2015-04       Impact factor: 1.690

3.  Accurate and precise plasma clearance measurement using four 99mTc-DTPA plasma samples over 4 h.

Authors:  Surajith N Wanasundara; Michal J Wesolowski; Mark C Barnfield; Michael L Waller; Anthony W Murray; Maria T Burniston; Paul S Babyn; Carl A Wesolowski
Journal:  Nucl Med Commun       Date:  2016-01       Impact factor: 1.690

4.  Time Varying Apparent Volume of Distribution and Drug Half-Lives Following Intravenous Bolus Injections.

Authors:  Carl A Wesolowski; Michal J Wesolowski; Paul S Babyn; Surajith N Wanasundara
Journal:  PLoS One       Date:  2016-07-12       Impact factor: 3.240

5.  A gamma-distribution convolution model of 99mTc-MIBI thyroid time-activity curves.

Authors:  Carl A Wesolowski; Surajith N Wanasundara; Michal J Wesolowski; Belkis Erbas; Paul S Babyn
Journal:  EJNMMI Phys       Date:  2016-12-16

6.  Comparison of the gamma-Pareto convolution with conventional methods of characterising metformin pharmacokinetics in dogs.

Authors:  Carl A Wesolowski; Surajith N Wanasundara; Paul S Babyn; Jane Alcorn
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-12-21       Impact factor: 2.745

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.